Frank Raimondi

Vice President of Channel Development

With over 30 years of outstanding background in the IT/PC channels, Frank Raimondi utilizes his strong relationships with vendors, distributors, and reseller partners to work with multiple parties, together toward a greater goal, through alliance and partnership marketing, event production and management, strategy development, and complete follow through to execution.
 
Frank currently is the vice president of channel development for Nodeware, an MSP-focused tool that delivers complete visibility of your network, real-time discovery of devices, and prioritization of security gaps (vulnerabilities). He also is a lead consultant with Strategic Channel Concepts (SCC) and The ICN Group, supporting organizations with their international and domestic channel business development efforts. Recent and past clients include startups and established companies such as Intel, ECS, CompTIA, ATTO Technology, Absolute Software, Higher Ground Gear, Chargifi, Kickpost, Vedamo, VidBid, and MarketStar.

Prior to this, Frank was the worldwide channel alliances manager for the direct and channel sales group at Intel. In this role, he was responsible for working with a wide variety of hardware, software, and services companies to improve the profitability and viability of the Intel Technology Provider members around the world. He was intricately involved with multiple business units at Intel to provide channel knowledge and access.

Frank has also held management and executive positions at Intel, NASBA, Synnex, and Apple Computer.

Additionally, Frank was a national board member of the nonprofit Community Health Charities (www.healthcharities.org), a guest lecturer at UC Davis, and provides additional marketing and business development support to other nonprofits. He also participates as a faculty member for CompTIA, presenting at industry conferences on their behalf, and most recently is a member of the Washington County (OR) Medical Reserve Corps, actively participating in the Covid-19 vaccine rollout.